MedTrace Logo

A Pharmacodynamic Study of SLM0807, HKB0701 and CJ30001 in Healthy Subject

NCT01380873 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2011-06-27

No results posted yet for this study

Summary

This trial is conducted to

1. assess whether SLM0807 alters pharmacodynamics of HKB0701
2. estimate the pharmacodynamics of HKB0701 after multiple administration of CJ30001 and multiple co-administration of HKB0701/SLM0807 in healthy subject

Conditions

Interventions

DRUG

Period I : HKB0701, Period II : HKB0701 and SLM0807, Period III : CJ30001

DRUG

Period I : HKB0701 and SLM0807, Period II : CJ30001, Period III : HKB0701

DRUG

Period I : CJ30001, Period II : HKB0701, Period III : HKB0701 and SLM0807

Sponsors & Collaborators

  • HK inno.N Corporation

    lead INDUSTRY

Principal Investigators

  • Jae Gook Shin, MD, ph D · Inje University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2010-02-28
Completion
2010-03-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01380873 on ClinicalTrials.gov